PubMed:16920333 / 1162-1318 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T7 0-156 Sentence denotes No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
3378 22-45 ChemicalEntity denotes eslicarbazepine acetate MESH:C416835

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T21 38-45 GeneOrGeneProduct denotes acetate
T22 67-77 GeneOrGeneProduct denotes behavioral
T23 116-127 GeneOrGeneProduct denotes wakefulness
T24 128-133 GeneOrGeneProduct denotes cycle

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T13 128-133 GeneOrGeneProduct denotes cycle

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T26 22-45 ChemicalEntity denotes eslicarbazepine acetate C416835|http://purl.obolibrary.org/obo/CHEBI_87016
T28 78-81 ChemicalEntity denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494

LitCoin-training-merged

Id Subject Object Predicate Lexical cue ID:
T28 78-81 ChemicalEntity denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T26 22-45 ChemicalEntity denotes eslicarbazepine acetate http://purl.obolibrary.org/obo/CHEBI_87016|C416835